Mesothelioma

An immunotherapy pair looks promising for those with pleural mesothelioma, which is now treated with chemotherapy.

Clinical trials of combination immunotherapy treatments are showing impressive overall survival rates.

After a shocking diagnosis, Heather Von St. James is on a mission to spread awareness about mesothelioma.

Immune checkpoint inhibitors have demonstrated encouraging results for patients with small cell lung cancer (SCLC) and mesothelioma, two aggressive thoracic malignancies with few options.

An ambitious clinical trial set to start in July will match patients to treatments based on molecular abnormalities, rather than cancer types, testing 20 targeted drugs at once.

Finding specialized care is worth the effort for patients with uncommon cancers.

Readers respond to past CURE articles on living with mesothelioma, hospice, beating bladder cancer, lung cancer, and response to CURE's 2007 Cancer Resource Guide.

Asbestos exposure is the main cause of mesothelioma, accounting for more than 80 percent of cases.